Skip to content
Markets News
Stocks1 min read

Integer’s Pending Buyout Offers $127 Per Share as Sales Lag

Makkler Newsroom
September 29, 2026

A proposed cash acquisition gives Integer shareholders a defined price, while slow adoption of new products weighs on quarterly sales and margins.

Integer Holdings has agreed to be acquired by affiliates of Kohlberg Kravis Roberts for $127 in cash per eligible share at closing. The deal remains subject to conditions, including approval from holders of a majority of outstanding shares and regulatory clearances.

The acquisition has no financing condition, and the buyer has obtained equity and debt financing commitments. If completed, Integer would become a wholly owned subsidiary of the buyer and its shares would be delisted from the NYSE.

The pending deal comes as new-product adoption weighs on results. Integer’s second-quarter sales fell 2.6% year over year to $464.1 million, while adjusted earnings per share rose 3.2%. Lower production volumes also reduced fixed-cost absorption, and gross margin fell to 24.3% from 27.1% a year earlier.

Two new electrophysiology products contributed to a 2% decline in Cardio & Vascular sales, to $280.3 million. Cardiac Rhythm Management & Neuromodulation sales rose 1% to $173.7 million, despite softness in one neuromodulation product.

Integer has identified three recently launched products as a key drag on its 2026 outlook. Zacks said its consensus estimate for Integer’s 2026 earnings remained at $6.09 per share over the past 30 days. Its estimate for third-quarter sales is $457.3 million, down 2.2% from a year earlier.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.